BMS 1612 (Baraclude 1 mg)

Generic Name: entecavir

Pill imprint BMS 1612 has been identified as Baraclude 1 mg.

Baraclude is used in the treatment of hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Baraclude 1 mg is not a controlled substance under the Controlled Substance Act (CSA).

Baraclude

Generic Name:

entecavir

Imprint:

BMS 1612

Strength:

1 mg

Color:

Pink

Shape:

Three-sided

Availability:

Prescription only

Drug Class:

Nucleoside reverse transcriptase inhibitors (NRTIs)

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Bristol-Myers Squibb

National Drug Code (NDC):

00003-1612

Inactive Ingredients:

lactose monohydrate
microcrystalline cellulose
crospovidone
povidone
magnesium stearate
titanium dioxide
hypromelloses
polyethylene glycol 400
ferric oxide red

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
49884-0105	Par Pharmaceutical, Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.